FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2999392246> ?p ?o ?g. }

• W2999392246 endingPage "161" @default.
• W2999392246 startingPage "147" @default.
• W2999392246 abstract "Background and aim: Sodium-glucose cotransporter (SGLT) 2 is responsible for most of the glucose reabsorption in the kidneys and has been proposed as a novel therapeutic target for the treatment of type 2 diabetes. In recent years, nonalcoholic steatohepatitis (NASH), the pathogenesis of which is strongly associated with insulin resistance, obesity, and type 2 diabetes, has become a considerable healthcare burden worldwide. However, there is currently no established pharmacotherapy for NASH. Here, we investigated the therapeutic effects of the SGLT2 selective inhibitor ipragliflozin alone and in combination with metformin on NASH in high fat and cholesterol diet-fed KK/Ay type 2 diabetic mice.Results: This diabetic model had hyperglycemia, insulin resistance, and obesity, and also exhibited steatosis, inflammation, and fibrosis in the liver, pathological features resembling those in human NASH. Four-week repeated administration of ipragliflozin significantly improved not only hyperglycemia, insulin resistance, and obesity but also hyperlipidemia and NASH-associated symptoms including hepatic steatosis and fibrosis. In addition, ipragliflozin attenuated inflammation and oxidative stress in the liver. Repeated administration of metformin also significantly improved symptoms of type 2 diabetes with NASH to a comparable degree to that by ipragliflozin. In addition, combination treatment with ipragliflozin and metformin additively improved these symptoms.Conclusions: These results demonstrate that the SGLT2 selective inhibitor ipragliflozin improves not only hyperglycemia but also NASH in type 2 diabetic mice, suggesting that treatment with ipragliflozin alone and in combination with metformin may be effective for treating type 2 diabetes with NASH." @default.
• W2999392246 created "2020-01-23" @default.
• W2999392246 creator A5017481949 @default.
• W2999392246 creator A5080346888 @default.
• W2999392246 date "2020-01-18" @default.
• W2999392246 modified "2023-09-27" @default.
• W2999392246 title "Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice" @default.
• W2999392246 cites W1523155649 @default.
• W2999392246 cites W1868475579 @default.
• W2999392246 cites W1899522935 @default.
• W2999392246 cites W1976509021 @default.
• W2999392246 cites W1978666738 @default.
• W2999392246 cites W1996482353 @default.
• W2999392246 cites W2010662354 @default.
• W2999392246 cites W2014770821 @default.
• W2999392246 cites W2016103822 @default.
• W2999392246 cites W2017849767 @default.
• W2999392246 cites W2024214508 @default.
• W2999392246 cites W2059196301 @default.
• W2999392246 cites W2066088297 @default.
• W2999392246 cites W2069845056 @default.
• W2999392246 cites W2078690570 @default.
• W2999392246 cites W2079454650 @default.
• W2999392246 cites W2083685463 @default.
• W2999392246 cites W2095574383 @default.
• W2999392246 cites W2100377684 @default.
• W2999392246 cites W2126753352 @default.
• W2999392246 cites W2132866343 @default.
• W2999392246 cites W2133795831 @default.
• W2999392246 cites W2159773554 @default.
• W2999392246 cites W2161311866 @default.
• W2999392246 cites W2164118055 @default.
• W2999392246 cites W2186318742 @default.
• W2999392246 cites W2217349032 @default.
• W2999392246 cites W2299455978 @default.
• W2999392246 cites W2341165197 @default.
• W2999392246 cites W2398592169 @default.
• W2999392246 cites W2561077285 @default.
• W2999392246 cites W2577902252 @default.
• W2999392246 cites W2615637571 @default.
• W2999392246 cites W2730267177 @default.
• W2999392246 cites W4229980607 @default.
• W2999392246 cites W4230554375 @default.
• W2999392246 cites W4246970444 @default.
• W2999392246 doi "https://doi.org/10.1080/07435800.2020.1713802" @default.
• W2999392246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31955626" @default.
• W2999392246 hasPublicationYear "2020" @default.
• W2999392246 type Work @default.
• W2999392246 sameAs 2999392246 @default.
• W2999392246 citedByCount "7" @default.
• W2999392246 countsByYear W29993922462020 @default.
• W2999392246 countsByYear W29993922462021 @default.
• W2999392246 countsByYear W29993922462022 @default.
• W2999392246 crossrefType "journal-article" @default.
• W2999392246 hasAuthorship W2999392246A5017481949 @default.
• W2999392246 hasAuthorship W2999392246A5080346888 @default.
• W2999392246 hasConcept C126322002 @default.
• W2999392246 hasConcept C134018914 @default.
• W2999392246 hasConcept C2776175330 @default.
• W2999392246 hasConcept C2777180221 @default.
• W2999392246 hasConcept C2777391703 @default.
• W2999392246 hasConcept C2778772119 @default.
• W2999392246 hasConcept C2779134260 @default.
• W2999392246 hasConcept C2779478299 @default.
• W2999392246 hasConcept C2780323712 @default.
• W2999392246 hasConcept C2910068830 @default.
• W2999392246 hasConcept C555293320 @default.
• W2999392246 hasConcept C71924100 @default.
• W2999392246 hasConcept C98274493 @default.
• W2999392246 hasConceptScore W2999392246C126322002 @default.
• W2999392246 hasConceptScore W2999392246C134018914 @default.
• W2999392246 hasConceptScore W2999392246C2776175330 @default.
• W2999392246 hasConceptScore W2999392246C2777180221 @default.
• W2999392246 hasConceptScore W2999392246C2777391703 @default.
• W2999392246 hasConceptScore W2999392246C2778772119 @default.
• W2999392246 hasConceptScore W2999392246C2779134260 @default.
• W2999392246 hasConceptScore W2999392246C2779478299 @default.
• W2999392246 hasConceptScore W2999392246C2780323712 @default.
• W2999392246 hasConceptScore W2999392246C2910068830 @default.
• W2999392246 hasConceptScore W2999392246C555293320 @default.
• W2999392246 hasConceptScore W2999392246C71924100 @default.
• W2999392246 hasConceptScore W2999392246C98274493 @default.
• W2999392246 hasIssue "2" @default.
• W2999392246 hasLocation W29993922461 @default.
• W2999392246 hasLocation W29993922462 @default.
• W2999392246 hasOpenAccess W2999392246 @default.
• W2999392246 hasPrimaryLocation W29993922461 @default.
• W2999392246 hasRelatedWork W2011686558 @default.
• W2999392246 hasRelatedWork W2017554448 @default.
• W2999392246 hasRelatedWork W2022982729 @default.
• W2999392246 hasRelatedWork W2044823377 @default.
• W2999392246 hasRelatedWork W2056505063 @default.
• W2999392246 hasRelatedWork W2147350783 @default.
• W2999392246 hasRelatedWork W2159123653 @default.
• W2999392246 hasRelatedWork W2590309358 @default.
• W2999392246 hasRelatedWork W2744240433 @default.
• W2999392246 hasRelatedWork W2765105402 @default.
• W2999392246 hasVolume "45" @default.

• next